Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Урогенитальные заболевания, вызванные генитальными микоплазмами (Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis)
Урогенитальные заболевания, вызванные генитальными микоплазмами (Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis)
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Полный текст
Список литературы
1. Robertson JA et al. Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans. J Clin Microbiol 1982; 15: 873–8.
2. Robertson JA et al. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol 1993; 31: 824–30.
3. Robertson JA et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard M et al. 1974). Int J Syst Evol Microbiol 2002; 52: 587–97.
4. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in Women the «New Chlamydia?». A Community-Based Prospective Cohort Study. Clin Infect Dis 2010 15; 51 (10): 1160–6.
5. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359 (9308): 765–6.
6. Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006: 30184.
7. Henry CH, Hughes CV, Gerard HC et al. Reactive arthritis: preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000; 58 (10): 1137–42; discussion 43–4.
8. Yokoi S, Maeda S, Kubota Y et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis 2007; 45 (7): 866–71.
9. Povlsen K, Bjornelius E, Lidbrink P, Lind I. Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Infect Dis 2002; 21 (2): 97–101.
10. WHO 2006. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015: breaking the chain of transmission. Available at: http://whqlibdoc.who.int/publications/2007/9789244563472_rus.pdf. last access 19, Sept 2010.
11. Centers for Disease Control and Prevention. STD Treatment Guidelines 2010. Morbidity and Mortality Weekly Report (MMWR) 2010; 59 (RR-12): 1–114.
12. Manhart LE, Critchlow CW, Holmes KK et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187 (4): 650–7.
13. McGowin CL, Spagnuolo RA, Pyles RB. Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infection and immunity 2010; 78 (2): 726–36. Preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000; 58 (10): 1137–42; discussion 43–4.
14. Taylor-Robinson D, Renton A, Jensen JS et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD & AIDS 2009; 20 (4): 234–7.
15. Manhart LE, Golden MR, Marrazzo JM. Expanding the spectrum of pathogens in urethritis: implications for presumptive therapy? Clin Infect Dis 2007; 45 (7): 872–4.
16. Савичева АМ, Шипицына ЕВ, Золотоверхая ЕА et al. Лабораторная диагностика инфекции, вызванной Mycoplasma genitalium. Метод. рекомендации. СПб.: Н-Л, 2010.
17. Shipitsyna E, Savicheva A, Solokovskiy E et al. Guidelines for the laboratory diagnosis of Mycoplasma genitalium infections in East European countries. Acta Derm Venereol 2010; 90 (5): 461–7.
18. Савичева А.М., Соколовский Е.В., Домейка М. и др. Методические материалы по диагностике, лечению и профилактике наиболее распространенных инфекций, передаваемых половым путем. Методич. пособие. СПб: Н-Л, 2002.
19. Гущин А.Е., Бурцев О.А., Рыжих П.Г. и др. Мониторинг лечения пациентов с инфекцией, вызванной Mycoplasma genitalium с помощью методов ПЦР и НАСБА в реальном времени. Клинич. дерматол. и венерол. 2009; 4: 58–63.
20. Bjornelius E, Anagrius C, Bojs G et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84 (1): 72–6.
21. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008; 3 (11): e3618.
22. Skerk V, Schonwald S, Krhen I et al. Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. Drugs Exp Clin Res 2001; 27 (4): 135–9.
23. Савичева А.М., Чхартишвили М.Г., Золотоверхая Е.А., Шипицына Е.В. Эффективность доксициклина при лечении урогенитальных инфекций, ассоциированных с уреаплазмами. Гинекология. 2009; 11 (6): 38–41.
24. Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med 1999; 8 (1): 12–6.
25. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 2010; 16 (11): 1649–55.
2. Robertson JA et al. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol 1993; 31: 824–30.
3. Robertson JA et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard M et al. 1974). Int J Syst Evol Microbiol 2002; 52: 587–97.
4. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in Women the «New Chlamydia?». A Community-Based Prospective Cohort Study. Clin Infect Dis 2010 15; 51 (10): 1160–6.
5. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359 (9308): 765–6.
6. Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006: 30184.
7. Henry CH, Hughes CV, Gerard HC et al. Reactive arthritis: preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000; 58 (10): 1137–42; discussion 43–4.
8. Yokoi S, Maeda S, Kubota Y et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis 2007; 45 (7): 866–71.
9. Povlsen K, Bjornelius E, Lidbrink P, Lind I. Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Infect Dis 2002; 21 (2): 97–101.
10. WHO 2006. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015: breaking the chain of transmission. Available at: http://whqlibdoc.who.int/publications/2007/9789244563472_rus.pdf. last access 19, Sept 2010.
11. Centers for Disease Control and Prevention. STD Treatment Guidelines 2010. Morbidity and Mortality Weekly Report (MMWR) 2010; 59 (RR-12): 1–114.
12. Manhart LE, Critchlow CW, Holmes KK et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187 (4): 650–7.
13. McGowin CL, Spagnuolo RA, Pyles RB. Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infection and immunity 2010; 78 (2): 726–36. Preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000; 58 (10): 1137–42; discussion 43–4.
14. Taylor-Robinson D, Renton A, Jensen JS et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD & AIDS 2009; 20 (4): 234–7.
15. Manhart LE, Golden MR, Marrazzo JM. Expanding the spectrum of pathogens in urethritis: implications for presumptive therapy? Clin Infect Dis 2007; 45 (7): 872–4.
16. Савичева АМ, Шипицына ЕВ, Золотоверхая ЕА et al. Лабораторная диагностика инфекции, вызванной Mycoplasma genitalium. Метод. рекомендации. СПб.: Н-Л, 2010.
17. Shipitsyna E, Savicheva A, Solokovskiy E et al. Guidelines for the laboratory diagnosis of Mycoplasma genitalium infections in East European countries. Acta Derm Venereol 2010; 90 (5): 461–7.
18. Савичева А.М., Соколовский Е.В., Домейка М. и др. Методические материалы по диагностике, лечению и профилактике наиболее распространенных инфекций, передаваемых половым путем. Методич. пособие. СПб: Н-Л, 2002.
19. Гущин А.Е., Бурцев О.А., Рыжих П.Г. и др. Мониторинг лечения пациентов с инфекцией, вызванной Mycoplasma genitalium с помощью методов ПЦР и НАСБА в реальном времени. Клинич. дерматол. и венерол. 2009; 4: 58–63.
20. Bjornelius E, Anagrius C, Bojs G et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84 (1): 72–6.
21. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008; 3 (11): e3618.
22. Skerk V, Schonwald S, Krhen I et al. Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. Drugs Exp Clin Res 2001; 27 (4): 135–9.
23. Савичева А.М., Чхартишвили М.Г., Золотоверхая Е.А., Шипицына Е.В. Эффективность доксициклина при лечении урогенитальных инфекций, ассоциированных с уреаплазмами. Гинекология. 2009; 11 (6): 38–41.
24. Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med 1999; 8 (1): 12–6.
25. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 2010; 16 (11): 1649–55.
Авторы
М.Р.Рахматулина
ФГБУ Государственный научный центр дерматовенерологии и косметологии, Москва
ФГБУ Государственный научный центр дерматовенерологии и косметологии, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.